Heart Test Laboratories Inc (HSCS) Stock Price, Quote & News

Company Profile

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insig...

Industry: Medical Devices

Sector: Healthcare

Phone: 682 237 7781

Website: heartsciences.com

Address:

550 Reserve Street, Suite 360, Southlake, United States

DrTampa Sep. 14 at 8:37 AM

$HSCS hope all y'all longs had a great weekend!

0 · Reply

DrTampa Sep. 11 at 3:27 PM

$HSCS latest short interest numbers show shorts were on the rise at the end of August. $CYPH also saw a slight SI increase. $ZEC.X

0 · Reply

DrTampa Sep. 10 at 5:06 PM

$HSCS 15% down for nothing other than stopping you out of your shares, so I added some more today!

0 · Reply

DrTampa Sep. 9 at 2:12 PM

$HSCS it says our low of the day is 3.88, so why TF hasn't my 3.90 bid filled fully?

1 · Reply

Moneyybaggs Sep. 9 at 1:06 PM

$HSCS QUESTION OF THE WEEK……….. Does ZEC hit $1,500 by COB on Friday?!?

0 · Reply

DrTampa Sep. 9 at 8:37 AM

$HSCS algos working early this morning 😂🤷 y'all ain't getting my shares cheap! how's things looking at $CYPH this morning since $ZEC is like $1250?!?

0 · Reply

DrTampa Sep. 9 at 8:16 AM

$HSCS i ain't never seen it so this before 😂😂🤷 4.20s not here mannnn 😝😝 $CYPH $ZEC

0 · Reply

DrTampa Sep. 9 at 12:04 AM

$HSCS mmmmm 5,000 bid at $4.03 🤑🤑🤑 someone tryna buy in 📈📈 $CYPH $ZEC

0 · Reply

DrTampa Sep. 8 at 4:52 PM

$HSCS peep the unrealized gains. I've been in the stock for 3 years and I'm not selling for fking pennies. this thing should be like at least $10, but I see $20 to $30 potential with $ZEC over $1000 and Fortitude merger, even fully diluted. LFGGGGG 📈📈🤑🫡 $CYPH is the sister play 🤑📈?

0 · Reply

DrTampa Sep. 8 at 4:26 PM

$HSCS becareful if you sell shares, algos are not giving anything back! They don't want to close my bid orders 🤑🤑 only way to close and get some shares is to pay the ask! 📈📈 how y'all doing today at $CYPH ?!? LFG $ZEC!!!

0 · Reply

HeartSciences Proxy statement: Proxy filing

Sep 10, 2026, 8:00 AM EDT - 4 days ago

HeartSciences Proxy statement: Proxy filing

Sep 10, 2026, 8:00 AM EDT - 4 days ago

HeartSciences Proxy statement: Proxy filing

Sep 9, 2026, 8:00 AM EDT - 5 days ago

HeartSciences Proxy statement: Proxy filing

Sep 9, 2026, 8:00 AM EDT - 5 days ago

HeartSciences Proxy statement: Proxy filing

Sep 8, 2026, 8:00 AM EDT - 6 days ago

HeartSciences Proxy statement: Proxy filing

Sep 8, 2026, 8:00 AM EDT - 6 days ago

HeartSciences Proxy statement: Proxy filing

Sep 4, 2026, 8:00 AM EDT - 10 days ago

HeartSciences Proxy statement: Proxy filing

Sep 4, 2026, 8:00 AM EDT - 10 days ago

HeartSciences Proxy statement: Proxy filing

Sep 3, 2026, 8:00 AM EDT - 11 days ago

HeartSciences Proxy statement: Proxy filing

Sep 2, 2026, 8:00 AM EDT - 12 days ago

HeartSciences Proxy statement: Proxy filing

Sep 1, 2026, 8:00 AM EDT - 13 days ago

HeartSciences Proxy statement: Proxy filing

Aug 31, 2026, 8:00 AM EDT - 14 days ago

HeartSciences Proxy statement: Proxy filing

Aug 31, 2026, 8:00 AM EDT - 14 days ago

HeartSciences Proxy statement: Proxy filing

Aug 28, 2026, 8:00 AM EDT - 17 days ago

HeartSciences Proxy statement: Proxy filing

Aug 27, 2026, 8:00 AM EDT - 18 days ago

HeartSciences Proxy statement: Proxy filing

Aug 25, 2026, 8:00 AM EDT - 20 days ago

HeartSciences Proxy statement: Proxy filing

Aug 24, 2026, 8:00 AM EDT - 21 days ago

HeartSciences Proxy statement: Proxy filing

Aug 21, 2026, 8:00 AM EDT - 24 days ago

HeartSciences Proxy statement: Proxy filing

Aug 20, 2026, 8:00 AM EDT - 25 days ago

HeartSciences Proxy statement: Proxy filing

2026-08-19T13:10:50.000Z - 26 days ago

Fortitude Mining purchases 411,522 shares of HeartSciences in private placement

Aug 19, 2026, 9:00 AM EDT - 26 days ago

Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration

Aug 19, 2026, 8:00 AM EDT - 26 days ago

HeartSciences Proxy statement: Proxy filing

Aug 19, 2026, 8:00 AM EDT - 26 days ago

HeartSciences Proxy statement: Proxy filing

Aug 18, 2026, 8:00 AM EDT - 27 days ago

HeartSciences Proxy statement: Proxy filing

Aug 7, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

Aug 6, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

Aug 4, 2026, 8:00 AM EDT - 5 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 30, 2026, 8:00 AM EDT - 6 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 29, 2026, 9:00 AM EDT - 6 weeks ago

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

Jul 29, 2026, 8:00 AM EDT - 6 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 29, 2026, 8:00 AM EDT - 6 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 28, 2026, 8:00 AM EDT - 6 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 28, 2026, 8:00 AM EDT - 6 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 27, 2026, 8:00 AM EDT - 7 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 27, 2026, 8:00 AM EDT - 7 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 27, 2026, 8:00 AM EDT - 7 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 23, 2026, 5:15 PM EDT - 7 weeks ago

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

Jul 23, 2026, 8:00 AM EDT - 7 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 23, 2026, 7:00 AM EDT - 7 weeks ago

HeartSciences Annual report: Q4 2026

Jul 23, 2026, 7:00 AM EDT - 7 weeks ago

HeartSciences Earnings release: Q4 2026

Jul 22, 2026, 8:00 AM EDT - 7 weeks ago

HeartSciences Proxy statement: Proxy filing

Jul 10, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

Jun 25, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

Jun 24, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

2026-06-23T14:26:04.000Z - 2 months ago

HeartSciences, Fortitude announces business combination

Jun 23, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

Jun 23, 2026, 8:00 AM EDT - 2 months ago

HeartSciences Proxy statement: Proxy filing

Jun 23, 2026, 7:30 AM EDT - 2 months ago

Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

Jun 23, 2026, 7:00 AM EDT - 2 months ago

HeartSciences Slides: Investor presentation

2026-06-11T13:48:30.000Z - 3 months ago

HeartSciences granted European patent for heart-monitoring technology

Jun 11, 2026, 8:30 AM EDT - 3 months ago

European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents

Jun 2, 2026, 8:30 AM EDT - 3 months ago

HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm

2026-05-19T12:51:09.000Z - 3 months ago

HeartSciences enters commercial agreement with North Shore Health

May 19, 2026, 8:30 AM EDT - 3 months ago

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

2026-05-05T13:47:14.000Z - 4 months ago

HeartSciences signs MyoVista commercial agreement with St. Vincent Health

May 5, 2026, 9:00 AM EDT - 4 months ago

HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™

Apr 14, 2026, 4:15 PM EDT - 5 months ago

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Mar 25, 2026, 8:30 AM EDT - 5 months ago

HeartSciences' MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Mar 24, 2026, 11:18 AM EDT - 5 months ago

HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Mar 19, 2026, 8:00 AM EDT - 5 months ago

HeartSciences Proxy statement: Proxy filing

Mar 17, 2026, 8:00 AM EDT - 6 months ago

HeartSciences Proxy statement: Proxy filing

Mar 16, 2026, 4:15 PM EDT - 6 months ago

HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Mar 16, 2026, 8:00 AM EDT - 6 months ago

HeartSciences Quarterly report: Q3 2026

Mar 16, 2026, 8:00 AM EDT - 6 months ago

HeartSciences Earnings release: Q3 2026

Mar 6, 2026, 7:00 AM EST - 6 months ago

HeartSciences Proxy statement: Proxy filing

2026-02-05T13:47:11.000Z - 7 months ago

HeartSciences announces UWE adopted MyoVista Insights, MyoVista wavECG

Feb 5, 2026, 8:30 AM EST - 7 months ago

University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

2026-01-29T13:41:04.000Z - 7 months ago

HeartSciences MyoVista Insights selected by Cibolo Rural Health Networks

Jan 29, 2026, 8:30 AM EST - 7 months ago

Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Dec 15, 2025, 4:15 PM EST - 9 months ago

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

2025-12-15T13:35:23.000Z - 9 months ago

HeartSciences announces FDA 510(k) submission for MyoVista wavECG

Dec 15, 2025, 8:30 AM EST - 9 months ago

HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Dec 15, 2025, 7:00 AM EST - 9 months ago

HeartSciences Quarterly report: Q2 2026

Dec 15, 2025, 7:00 AM EST - 9 months ago

HeartSciences Earnings release: Q2 2026

2025-12-11T13:46:02.000Z - 9 months ago

HeartSciences announces commercial release of MyoVista Insights version 1.1

Dec 11, 2025, 8:30 AM EST - 9 months ago

HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Sep 12, 2025, 7:00 AM EDT - 1 year ago

HeartSciences Slides: Investor presentation

Sep 11, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Sep 11, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Quarterly report: Q1 2026

Sep 11, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q1 2026

Aug 15, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Conference Participation and Investor Webinar

Jul 24, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results

Jul 24, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Annual report: Q4 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q4 2025

2025-06-04T13:06:22.000Z - 1 year ago

HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm

Jun 4, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

2025-06-03T13:05:37.000Z - 1 year ago

HeartSciences announces grant by USPTO for ECG assessment of heart function

Jun 3, 2025, 9:00 AM EDT - 1 year ago

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value

2025-05-29T13:05:18.000Z - 1 year ago

HeartSciences signs first MyoVista Insights platform customer

May 29, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

May 20, 2025, 9:00 AM EDT - 1 year ago

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

May 8, 2025, 9:00 AM EDT - 1 year ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

2025-05-07T13:06:44.000Z - 1 year ago

HeartSciences appoints Nadkarni, Lampart, Vai to Scientific Advisory Board

May 7, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

2025-05-01T13:28:48.000Z - 1 year ago

HeartSciences launches MyoVista Insights platform

May 1, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

Mar 13, 2025, 4:15 PM EDT - 1 year ago

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Mar 13, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Quarterly report: Q3 2025

Mar 13, 2025, 8:00 AM EDT - 1 year ago

HeartSciences Earnings release: Q3 2025

Mar 10, 2025, 9:00 AM EDT - 1 year ago

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

Dec 16, 2024, 4:15 PM EST - 1 year ago

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Dec 16, 2024, 7:00 AM EST - 1 year ago

HeartSciences Quarterly report: Q2 2025

Dec 16, 2024, 7:00 AM EST - 1 year ago

HeartSciences Earnings release: Q2 2025

Nov 13, 2024, 9:00 AM EST - 1 year ago

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

Oct 14, 2024, 4:15 PM EDT - 1 year ago

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 27, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Registration statement: Registration filing

Sep 26, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Proxy statement: Proxy filing

Sep 18, 2024, 8:00 AM EDT - 1 year ago

HeartSciences Proxy statement: Proxy filing

Sep 12, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

Sep 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

Sep 12, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Quarterly report: Q1 2025

Sep 12, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q1 2025

Jul 29, 2024, 4:05 PM EDT - 2 years ago

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Jul 29, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Annual report: Q4 2024

Jul 29, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q4 2024

Jul 26, 2024, 9:00 AM EDT - 2 years ago

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Jul 25, 2024, 8:30 AM EDT - 2 years ago

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

Jul 11, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Jun 4, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Regains Compliance with Nasdaq Listing Requirements

May 20, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Apr 24, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Apr 2, 2024, 4:15 PM EDT - 2 years ago

HeartSciences to Present at the LD Micro Invitational XIV Conference

Mar 26, 2024, 9:00 AM EDT - 2 years ago

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Mar 14, 2024, 4:15 PM EDT - 2 years ago

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Mar 14, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Quarterly report: Q3 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

HeartSciences Earnings release: Q3 2024

Mar 12, 2024, 9:00 AM EDT - 2 years ago

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Mar 6, 2024, 9:00 AM EST - 2 years ago

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Mar 5, 2024, 7:00 AM EST - 2 years ago

HeartSciences Registration statement: Registration filing

Feb 26, 2024, 9:00 AM EST - 2 years ago

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Feb 12, 2024, 9:00 AM EST - 2 years ago

HeartSciences Expands its Scientific Advisory Board

Feb 1, 2024, 9:00 AM EST - 2 years ago

HeartSciences Appoints New Scientific Advisory Board Member

Jan 18, 2024, 8:00 AM EST - 2 years ago

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

DrTampa Sep. 14 at 8:37 AM

$HSCS hope all y'all longs had a great weekend!

0 · Reply

DrTampa Sep. 11 at 3:27 PM

$HSCS latest short interest numbers show shorts were on the rise at the end of August. $CYPH also saw a slight SI increase. $ZEC.X

0 · Reply

DrTampa Sep. 10 at 5:06 PM

$HSCS 15% down for nothing other than stopping you out of your shares, so I added some more today!

0 · Reply

DrTampa Sep. 9 at 2:12 PM

$HSCS it says our low of the day is 3.88, so why TF hasn't my 3.90 bid filled fully?

1 · Reply

Moneyybaggs Sep. 9 at 1:06 PM

$HSCS QUESTION OF THE WEEK……….. Does ZEC hit $1,500 by COB on Friday?!?

0 · Reply

DrTampa Sep. 9 at 8:37 AM

$HSCS algos working early this morning 😂🤷 y'all ain't getting my shares cheap! how's things looking at $CYPH this morning since $ZEC is like $1250?!?

0 · Reply

DrTampa Sep. 9 at 8:16 AM

$HSCS i ain't never seen it so this before 😂😂🤷 4.20s not here mannnn 😝😝 $CYPH $ZEC

0 · Reply

DrTampa Sep. 9 at 12:04 AM

$HSCS mmmmm 5,000 bid at $4.03 🤑🤑🤑 someone tryna buy in 📈📈 $CYPH $ZEC

0 · Reply

DrTampa Sep. 8 at 4:52 PM

0 · Reply

DrTampa Sep. 8 at 4:26 PM

0 · Reply

DrTampa Sep. 8 at 3:40 PM

$HSCS new 52-week high of $4.35 today, after setting the 52-week on Friday! Still ain't selling...and I'm sitting on 225,000 shares!

0 · Reply

topstockalerts Sep. 7 at 8:53 PM

$HSCS not seeing sellers show up yet… kinda wild

1 · Reply

DrTampa Sep. 6 at 6:41 PM

$HSCS as a long time heart sciences investor, I actually couldn't be happier about the proposed merger and I think $CYPH only helps both us as well as $ZEC 🤑🤑🤑 NFA but I'm still over here holding 225,000 shares of heart sciences long and strong!

0 · Reply

DrTampa Sep. 6 at 5:04 AM

$HSCS sweet jebus 👀👀🤑🤑🍻🥳🫡

0 · Reply

topstockalerts Sep. 4 at 9:32 PM

$HSCS not giving anything back… that’s strength

1 · Reply

DrTampa Sep. 4 at 7:41 PM

$HSCS we set the 52-week high today!!! resistance is at $3.78 and $3.80, and we already passed that today getting up to $3.83! could we see $4 today? maybe an after hours run?!?

0 · Reply

DrTampa Sep. 4 at 7:34 PM

$HSCS look at all those 100 blocks at the same time, which could be code for some MM algo saying they need shares.

1 · Reply

Moneyybaggs Sep. 4 at 5:20 PM

$HSCS Gotta love it when all other crypto coins are down but ZEC is not only up but up big!!! Love the slow and steady climb but with ZEC ripping everyday it’s only a matter of time before HSCS 🚀 🚀🚀!!!

0 · Reply

DrTampa Sep. 4 at 5:00 PM

$HSCS Inc we are less than 25 cents away from our one year high price, let's eat that quarter up y'all!

0 · Reply

WhitespringMcGee Sep. 4 at 4:26 PM

$HSCS Long weekend Friday afternoon and that’s enough for me. GL with the merger.

0 · Reply

TA_Kongen Sep. 4 at 10:28 AM

$HSCS IMO the best 'BET' if you wanna swing some ZCASH play. Quick DD on TUDE: - Fortitude controls roughly 18% of the entire Zcash network's mining power. - Fortitude's business model is explicitly anchored in mining and holding Zcash. - Once the business combination closes, DCG (Barry Silbert) is expected to control about 95% of the voting interests of the combined company.

0 · Reply

DrTampa Sep. 3 at 10:01 PM

$HSCS been some nice after hour orders, usually it's dead af after hours

0 · Reply

Market Cap	2.27M
Revenue (ttm)	20,000.00
Net Income (ttm)	-6.61M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	11,938
Avg Vol	455,542
Day's Range	N/A - N/A
Shares Out	656,000.00
Stochastic %K	24%
Beta	3.16
Analysts	Strong Sell
Price Target	$13.50